Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bramlage

Showing results (91-100 of 429) with videos related to

Pageof 43
Sort By:
Cardiovascular Diabetology|April 5, 2007
Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patientsUlrich Kintscher, Peter Bramlage, W Dieter Paar, et al.
Vascular Health and Risk Management|October 11, 2012
Diabetes prevalence and metabolic risk profile in an unselected population visiting pharmacies in SwitzerlandAlexandre Rey, Martin Thoenes, Rolf Fimmers, et al.
BMJ Open Diabetes Research & Care|August 25, 2022
Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300)Julia K Mader, Stefan Gölz, Stefan Bilz, et al.
Expert Opinion on Pharmacotherapy|July 16, 2009
The value of irbesartan in the management of hypertensionPeter Bramlage, Isabelle Durand-Zaleski, Nisha Desai, et al.
Journal of Cellular Biochemistry|March 14, 2002
Cardiac troponin I sense-antisense RNA duplexes in the myocardiumSvenia Podlowski, Peter Bramlage, Gert Baumann, et al.
Wiener Medizinische Wochenschrift (1946)|September 22, 2019
Aortic valve stenosis awareness in Austria-results of a nationwide survey in 1001 subjectsChristian Hengstenberg, Martin Thoenes, Peter Bramlage, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 4, 2011
Improvement of coronary microvascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertensionHarald Lethen, Hans-Peter Tries, Stefan Kersting, et al.
Thrombosis and Haemostasis|September 4, 2008
Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulcerationMatthias Weck, Hannes Rietzsch, Holger Lawall, et al.
Thrombosis and Haemostasis|October 28, 2010
Venous thromboembolism in medical outpatients - a cross-sectional survey of risk assessment and prophylaxisHolger Lawall, Andreas Matthiessen, Volker Hohmann, et al.
BMC Neurology|September 26, 2012
Microalbuminuria indicates long-term vascular risk in patients after acute stroke undergoing in-patient rehabilitationDirk Sander, Christian Weimar, Peter Bramlage, et al.
Pageof 43

Showing results (91-100 of 429) with videos related to

Sort By:
Pageof 43
Cardiovascular Diabetology|April 5, 2007
Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patientsUlrich Kintscher, Peter Bramlage, W Dieter Paar, et al.
Vascular Health and Risk Management|October 11, 2012
Diabetes prevalence and metabolic risk profile in an unselected population visiting pharmacies in SwitzerlandAlexandre Rey, Martin Thoenes, Rolf Fimmers, et al.
BMJ Open Diabetes Research & Care|August 25, 2022
Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300)Julia K Mader, Stefan Gölz, Stefan Bilz, et al.
Expert Opinion on Pharmacotherapy|July 16, 2009
The value of irbesartan in the management of hypertensionPeter Bramlage, Isabelle Durand-Zaleski, Nisha Desai, et al.
Journal of Cellular Biochemistry|March 14, 2002
Cardiac troponin I sense-antisense RNA duplexes in the myocardiumSvenia Podlowski, Peter Bramlage, Gert Baumann, et al.
Wiener Medizinische Wochenschrift (1946)|September 22, 2019
Aortic valve stenosis awareness in Austria-results of a nationwide survey in 1001 subjectsChristian Hengstenberg, Martin Thoenes, Peter Bramlage, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 4, 2011
Improvement of coronary microvascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertensionHarald Lethen, Hans-Peter Tries, Stefan Kersting, et al.
Thrombosis and Haemostasis|September 4, 2008
Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulcerationMatthias Weck, Hannes Rietzsch, Holger Lawall, et al.
Thrombosis and Haemostasis|October 28, 2010
Venous thromboembolism in medical outpatients - a cross-sectional survey of risk assessment and prophylaxisHolger Lawall, Andreas Matthiessen, Volker Hohmann, et al.
BMC Neurology|September 26, 2012
Microalbuminuria indicates long-term vascular risk in patients after acute stroke undergoing in-patient rehabilitationDirk Sander, Christian Weimar, Peter Bramlage, et al.
Pageof 43